» Articles » PMID: 30568493

Development of a Prediction Model for Pancreatic Cancer in Patients with Type 2 Diabetes Using Logistic Regression and Artificial Neural Network Models

Overview
Publisher Dove Medical Press
Specialty Oncology
Date 2018 Dec 21
PMID 30568493
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Patients with type 2 diabetes (T2DM) are suggested to have a higher risk of developing pancreatic cancer. We used two models to predict pancreatic cancer risk among patients with T2DM.

Methods: The original data used for this investigation were retrieved from the National Health Insurance Research Database of Taiwan. The prediction models included the available possible risk factors for pancreatic cancer. The data were split into training and test sets: 97.5% of the data were used as the training set and 2.5% of the data were used as the test set. Logistic regression (LR) and artificial neural network (ANN) models were implemented using Python (Version 3.7.0). The , precision, and recall were compared between the LR and the ANN models. The areas under the receiver operating characteristic (ROC) curves of the prediction models were also compared.

Results: The metrics used in this study indicated that the LR model more accurately predicted pancreatic cancer than the ANN model. For the LR model, the area under the ROC curve in the prediction of pancreatic cancer was 0.727, indicating a good fit.

Conclusion: Using this LR model, our results suggested that we could appropriately predict pancreatic cancer risk in patients with T2DM in Taiwan.

Citing Articles

Predicting the risk of pancreatic cancer in adults with new-onset diabetes: development and internal-external validation of a clinical risk prediction model.

Clift A, Tan P, Patone M, Liao W, Coupland C, Bashford-Rogers R Br J Cancer. 2024; 130(12):1969-1978.

PMID: 38702436 PMC: 11183048. DOI: 10.1038/s41416-024-02693-9.


Exploring the application and future outlook of Artificial intelligence in pancreatic cancer.

Zhao G, Chen X, Zhu M, Liu Y, Wang Y Front Oncol. 2024; 14:1345810.

PMID: 38450187 PMC: 10915754. DOI: 10.3389/fonc.2024.1345810.


An Integrative Pancreatic Cancer Risk Prediction Model in the UK Biobank.

Ke T, Lophatananon A, Muir K Biomedicines. 2023; 11(12).

PMID: 38137427 PMC: 10740416. DOI: 10.3390/biomedicines11123206.


A novel prediction model of the risk of pancreatic cancer among diabetes patients using multiple clinical data and machine learning.

Chen S, Phuc P, Nguyen P, Burton W, Lin S, Lin W Cancer Med. 2023; 12(19):19987-19999.

PMID: 37737056 PMC: 10587954. DOI: 10.1002/cam4.6547.


Studying infant mortality: A demographic analysis based on data mining models.

Satti M, Ali M, Irshad A, Shah M Open Life Sci. 2023; 18(1):20220643.

PMID: 37483426 PMC: 10358750. DOI: 10.1515/biol-2022-0643.


References
1.
Steyerberg E, Eijkemans M, Harrell Jr F, Habbema J . Prognostic modelling with logistic regression analysis: a comparison of selection and estimation methods in small data sets. Stat Med. 2000; 19(8):1059-79. DOI: 10.1002/(sici)1097-0258(20000430)19:8<1059::aid-sim412>3.0.co;2-0. View

2.
Yousaf U, Christensen M, Engholm G, Storm H . Suicides among Danish cancer patients 1971-1999. Br J Cancer. 2005; 92(6):995-1000. PMC: 2361949. DOI: 10.1038/sj.bjc.6602424. View

3.
Deyo R, Cherkin D, Ciol M . Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992; 45(6):613-9. DOI: 10.1016/0895-4356(92)90133-8. View

4.
Ahmed F . Artificial neural networks for diagnosis and survival prediction in colon cancer. Mol Cancer. 2005; 4:29. PMC: 1208946. DOI: 10.1186/1476-4598-4-29. View

5.
Hassan M, Bondy M, Wolff R, Abbruzzese J, Vauthey J, Pisters P . Risk factors for pancreatic cancer: case-control study. Am J Gastroenterol. 2007; 102(12):2696-707. PMC: 2423805. DOI: 10.1111/j.1572-0241.2007.01510.x. View